Hyperglucagonemia in Laennec's Cirrhosis: The Role of Portal-Systemic Shunting

New England Journal of Medicine

Volumn 290, Issue 5, 1974, Pages 239-242

  Sherwin, Robert ^a   Joshi, Prakash ^a   Hendler, Rosa ^a   Felig, Philip ^a   Conn, Harold O ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; AMMONIA; DIAGNOSTIC AGENT; GLUCAGON; INSULIN;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; BLOOD; ESOPHAGUS VARICES; FATTY LIVER; GLUCOSE BLOOD LEVEL; HUMAN; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PORTOCAVAL SHUNT; SECRETION;

ADOLESCENT; ADULT; AGED; ALANINE; ALCOHOLISM; AMINO ACIDS; AMMONIA; BLOOD GLUCOSE; ESOPHAGEAL AND GASTRIC VARICES; FATTY LIVER; GLUCAGON; HUMANS; INSULIN; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PORTACAVAL SHUNT, SURGICAL;

EID: 0016405651     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197401312900502     Document Type: Article

References (37)

1. Creutzfeldt W, Wille K, Kaup H: Intravenöse Belastungen mit Glucose, Insulin und Tolbutamid bei Gesunden, Diabetikern, Leberzirrhotikern und Isulomtrågern: (Zugleich ein Beitrag zum diagnostischen Wert des Tolbutamid-Tests). Dtsch Med Wochenschr 87: 2189–2195, 1962
2. Megyesi C, Samols E, Marks V: Glucose tolerance and diabetes in chronic liver disease. Lancet 2: 1051–1056, 1967
3. Conn HO, Schreiber W, Elkington SG: Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal–systemic shunting in Laennec's cirrhosis. Am J Dig Dis 16: 227–239, 1971
4. Podolsky S, Zimmerman HJ, Burrows BA, et al: Potassium depletion in hepatic cirrhosis: a reversible cause of impaired growth-hormone and insulin response to stimulation. N Engl J Med 288: 644–648, 1973
5. Conn HO: Portacaval anastomosis and hepatic hemosiderin deposition: a prospective, controlled investigation. Gastroenterology 62: 61–72, 1972
6. Conn HO, Daughaday WH: Cirrhosis and diabetes. V. Serum human growth hormone levels in cirrhosis. J Lab Clin Med 76: 678–688, 1970
7. Felig P, Wahren J: Etiology of glucose intolerance in liver disease: an hypothesis based upon observations in normal, diabetic and prediabetic subjects, Proceedings, Second International Beilinson Symposium on Diabetes in Juveniles. Edited by Z Laron, M Karp (in press)
8. Collins JR, Crofford OB: Glucose intolerance and insulin resistance in patients with liver disease. Arch Intern Med 124: 142–148, 1969
9. Conn HO, Schreiber W, Elkington SG, et al: Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis. Am J Dig Dis 14: 837–852, 1969
10. Rocha DM, Santeusanio F, Faloona GR, et al: Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med 288: 700–703, 1973
11. Marco J, Calle C, Román D, et al: Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med 288: 128–131, 1973
12. Wise JK, Hendler R, Felig P: Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J Clin Invest 52: 2774–2782, 1973
13. Unger RH: Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes 20: 834–838, 1971
14. Felig P, Pozefskv T, Marliss E, et al: Alanine: key role in gluconeogenesis. Science 167: 1003–1004, 1970
15. Wise JK, Hendler R, Felig P: Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects. N Engl J Med 288: 487–490, 1973
16. Conn HO, Ramsby GR: Angiographic diagnosis of patency of portacaval anastomosis. Am J Roentgenol Radium Ther Nucl Med (in press)
17. Conn HO: Ammonia tolerance as an index of portal–systemic collateral circulation in cirrhosis. Gastroenterology 41: 97–106, 1961
18. Snedecor GW, Cochran WG: Statistical Methods. Sixth edition. Ames, Iowa State University Press, 1967
19. Felig P, Brown WV, Levine RA, et al: Glucose homeostasis in viral hepatitis. N Engl J Med 283: 1436–1440, 1970
20. Seligson D, Hirahara K: The measurement of ammonia in whole blood, erythrocytes, and plasma. J Lab Clin Med 49: 962–974, 1957
21. Marco J, Diego J, Villanueva ML: Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med 289: 1107–1111, 1973
22. Assan R: In vivo metabolism of glucagon, Glucagon. Edited by PJ Lefebvre, RH Unger. Oxford, Pergamon Press, 1972, pp 47–59
23. Blackard WG, Nelson NC: Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19: 302–306, 1970
24. Assan R: Contribution to the study of glucagon secretion and catabolism in vivo, Diabetes (Proceedings of the Seventh Congress of the International Diabetes Federation) (International Congress Series No 231). Edited by RR Rodriguez, J Vallance-Owen. Amsterdam, Excerpta Medica, 1971, pp 610–624
25. Rocha DM, Faloona GR, Unger RH: Glucagon-stimulating activity of 20 amino acids in dogs. J Clin Invest 51: 2346–2351, 1972
26. Park CR, Exton JH: Glucagon and the metabolism of glucose, Glucagon. Edited by PJ Lefebvre, RH Unger. Oxford, Pergamon Press, 1972, pp 77–108
27. Danowski TS, Gillespie HK, Fergus EB, et al: Significance of blood sugar and serum electrolyte changes in cirrhosis following glucose, insulin, glucagon, or epinephrine. Yale J Biol Med 29: 361–375, 1956
28. Felig P: Interaction of insulin and amino acid metabolism in the regulation of gluconeogenesis. Isr J Med Sci 8: 262–270, 1972
29. Kreisberg RA, Siegal AM, Owen WC: Alanine and gluconeogenesis in man: effect of ethanol. J Clin Endocrinol Metab 34: 876–883, 1972
30. Levine RJ, Conn HO: Tyrosine metabolism in patients with liver disease. J Clin Invest 46: 2012–2020, 1967
31. Iber FL, Rosen H, Levenson SM, et al: The plasma amino acids in patients with liver failure. J Lab Clin Med 50: 417–425, 1957
32. Miller LL: The role of the liver and the nonhepatic tissues in the regulation of free amino acid levels in the blood, Amino Acid Pools: Distribution, formation and function of free amino acids. Edited by JT Holden. Amsterdam, Elsevier Publishing Company, 1962, pp 708–738
33. Felig P, Marliss E, Cahill GF Jr: Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281: 811–816, 1969
34. Pozefsky TJ, Felig P, Tobin JD, et al: Amino acid balance across tissues of the forearm in postabsorptive man: effects of insulin at two dose levels. J Clin Invest 48: 2273–2282, 1969
35. Creutzefeldt W, Frerichs H, Sickinger K: Liver diseases and diabetes mellitus. Prog Liver Dis 3: 371–407, 1970
36. Felig P: The glucose-alanine cycle. Metabolism 22: 179–207, 1973
37. Unger RH: Glucagon physiology and pathophysiology. N Engl J Med 285: 443–449, 1971